YAZ, Yasmin, and Ocella are birth control pills manufactured by Bayer Pharmaceuticals. Ocella is the generic form of Yasmin and is manufactured by Barr Laboratories. What makes these three medications different from other birth control pills is the addition of a new progestin called drospirenone. It has now been shown that drospirenone causes an increase and imbalance of the potassium levels in the body. Some of the side effects which have been noted by individuals taking YAZ, Yasmin or Ocella are the following:
- Blood Clots
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Gallbladder Disease or Removal
Late last year the number of lawsuits reportedly filed against the manufacturers of YAZ, Yasmin, and Ocella totaled approximately 150. Here is an update. The Bayer Pharmaceutical Annual Report 2009, which was published on February 26, 2010, stated that as of February 15, 2010, the number of lawsuits filed in connection with YAZ® and Yasmin® manufactured by Bayer totaled approximately 1,100. The number of lawsuits filed went from approximately 150 to 1,100 in just a 4–5 month period!
The Bayer Annual Report states,
“As of February 15, 2010, there were about 1,100 lawsuits pending in the United States served upon Bayer on behalf of persons alleged to have suffered personal injuries, some of them fatal, from the use of Bayer’s oral contraceptive products Yasmin®, YAZ®, and/or Ocella, a generic version of Yasmin® distributed by Barr Laboratories, Inc. in the U.S. market. Plaintiffs seek compensatory and punitive damages, claiming in particular that Bayer knew or should have known the alleged risks and should be held liable for having failed to disclose them or adequately warn users of Yasmin® and YAZ®.
The Report also states the following:
“All cases pending in the U.S. federal courts have been consolidated into multi-district litigation (MDL) proceeding for common pre-trial management. In addition, two Canadian class actions have been served upon Bayer. Additional lawsuits are anticipated. Bayer is also taking over Barr’s defense in certain cases according to the parties’ supply and licensing agreement.”
The Report also discloses that Canadians felt they had been adversely affected by these drugs since two Canadian class actions have been served.
Bayer acknowledges that additional lawsuits are expected in connection with these drugs.
To review Bayer’s 2009 Annual Report in its entirety, click here.
We continue to receive calls from women who have been adversely affected by YAZ, Yasmin, and Ocella. If you or someone you care about has suffered from any of the above symptoms after taking these drugs, please contact us. We would like to help.